Evidera
Michael Acquadro is a Research Associate III at Evidera, specializing in qualitative research, particularly in developing study forms, conducting interviews, analyzing data, reporting, and developing Patient-Reported Outcomes (PROs). Prior to this role, Michael worked at ICON plc as an Outcomes Researcher and Associate Outcomes Researcher, where a focus on gamification strategies to enhance patient participation in cognitive testing was a significant interest. Michael also contributed to qualitative research at Mapi Group and has a background in cognitive science, holding a PhD from Université Grenoble Alpes, along with a Master’s degree from Grenoble INP - Phelma and a License in Psychology from Ryerson University.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.